Item 5.07 Submission of Matters to a Vote of Security Holders

The American Bio Medica Corporation (the "Company") Annual Meeting (the "Annual Meeting") was held on June 23, 2022 at the Company's corporate offices in Kinderhook, New York. 24,930,930 shares of common stock, or 51.83% of the total shares of stock outstanding as of the record date of April 26, 2022, were present at the Annual Meeting in person or by proxy constituting a quorum.

At the Annual Meeting, stockholders voted on the following proposals and cast their vote as follows:

PROPOSAL NUMBER 1 - RATIFICATION OF AUDITORS

For Percent Against Percent Abstain Percent Broker Non-Votes 24,426,215 97.97% 478,214 1.92% 26,501 0.11% 0

PROPOSAL NUMBER 2 - approval of a non-binding advisory resolution regarding the compensation of the Company's Named Executive Officer

For Percent Against Percent Abstain Percent Broker Non-Votes 6,796,726 76.32% 1,512,621 16.99% 596,083 6.69% 16,025,500

A description of the proposals can be found in the Company's definitive proxy statement for the Annual Meeting filed with the U.S. Securities and Exchange Commission on April 28, 2022.

There were no nominees for election to the Board of Directors due to the number of directors and their staggered terms. All directors continued their terms of office after the Annual Meeting.

There were no other matters voted upon or discussed at the Annual Meeting other than the Proposals noted above.






2

© Edgar Online, source Glimpses